Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01916941 · ClinicalTrials.gov registry record · NA
Neural Mechanisms of Change During the Treatment of Alcohol Use Disorders With Prazosin
A NA study, sponsored by University of New Mexico.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT01916941 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 36 participants.
The verdict
NCT01916941, a NA study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The study uses neurobiological measures through brain imaging, neuropsychological measures, and selfreport measures to try to understand how an effective treatment for alcoholism works. On the whole, less than 50% of people with alcoholism get better with treatment. This study will help researchers develop better treatments for alcoholism because if the investigators know why the treatments the investigators use are working, and in whom the treatments work best, then the investigators may be able to make treatment more effective by targeting treatments to individuals who would be most likely to benefit and by guiding development of more effective treatments in the future.
Interventions
- DRUG Placebo
- DRUG Prazosin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2013-09 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01916941
The ClinicalTrials.gov registry entry for NCT01916941 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01916941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01916941 about?
NCT01916941 is a clinical study titled "Neural Mechanisms of Change During the Treatment of Alcohol Use Disorders With Prazosin". The study uses neurobiological measures through brain imaging, neuropsychological measures, and selfreport measures to try to understand how an effective treatment for alcoholism works. On the whole, less than 50% of people with alcoholism get better with treatment. This study will help researchers ...
What is the current status of trial NCT01916941?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2013-09. Estimated completion is 2017-09.
What interventions are being tested in trial NCT01916941?
The interventions under investigation include: Placebo (DRUG), Prazosin (DRUG).
Who is sponsoring clinical trial NCT01916941?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.